{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:41:32Z","timestamp":1760240492132,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.avsg.2020.12.018","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T09:46:57Z","timestamp":1611740817000},"page":"301-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Relationship between Serum YKL-40 Level and Forearm Arterial Patency after Repair"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3496-1155","authenticated-orcid":false,"given":"Ali Eray","family":"Gunay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Karaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4552-8098","authenticated-orcid":false,"given":"Zehra Filiz","family":"Karaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya","family":"Kocer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serap","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Saltuk","family":"Argun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2020.12.018_bib0001","first-page":"117","article-title":"Evaluation of forearm arterial repairs: functional outcomes related to arterial repair","volume":"23","author":"Keles","year":"2017","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"key":"10.1016\/j.avsg.2020.12.018_bib0002","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1053\/ajkd.2002.29886","article-title":"Hemodialysis vascular access survival: upper arm native arteriovenous fistula","volume":"39","author":"Dizon","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.avsg.2020.12.018_bib0003","doi-asserted-by":"crossref","first-page":"214","DOI":"10.5999\/aps.2018.00157","article-title":"Antithrombotic effect of epigallocatechin gallate on the patency of arterial microvascular anastomoses","volume":"46","author":"\u0130\u011fde","year":"2019","journal-title":"Arch Plast Surg"},{"key":"10.1016\/j.avsg.2020.12.018_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/229255039500300304","article-title":"Endothelialization after arterial and venous micro-anastomosis","volume":"3","author":"Harris","year":"1995","journal-title":"Can J Plast Surg"},{"issue":"suppl 1","key":"10.1016\/j.avsg.2020.12.018_bib0005","article-title":"Topical VEGF enhances healing of thoracic aortic anastomosis for coarctation in a rabbit model","volume":"108","author":"Seipelt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2020.12.018_bib0006","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5606\/ehc.2019.65584","article-title":"Is there an association of hematopoietic stem cell and endothelial progenitor cell markers with maturation in forearm arterial repair?","volume":"30","author":"Karaman","year":"2019","journal-title":"Eklem Hastalik Cerrahisi"},{"key":"10.1016\/j.avsg.2020.12.018_bib0007","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5551\/jat.26385","article-title":"The serum YKL-40 level is associated with vascular injury and predicts proteinuria in nephrotic syndrome patients","volume":"22","author":"Kocyigit","year":"2015","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.avsg.2020.12.018_bib0008","first-page":"351","article-title":"YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils","volume":"110","author":"Volck","year":"1998","journal-title":"Proc Assoc Am Physicians"},{"key":"10.1016\/j.avsg.2020.12.018_bib0009","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.lungcan.2004.11.011","article-title":"Expression of YKL-40 by eritumoral macrophages in human small cell lung cancer","volume":"48","author":"Junker","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.avsg.2020.12.018_bib0010","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/1535-7163.MCT-10-0868","article-title":"A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers","volume":"10","author":"Faibish","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.avsg.2020.12.018_bib0011","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1038\/onc.2009.292","article-title":"YKL-40, a secreted glycoprotein, promotes tumor angiogenesis","volume":"28","author":"Shao","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.avsg.2020.12.018_bib0012","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.biopha.2018.02.050","article-title":"Angiogenic potential of YKL-40 in the dynamics of tumor niche","volume":"100","author":"Pouyafar","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.avsg.2020.12.018_bib0013","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/micr.20645","article-title":"Assessment of the patency of microvascular anastomoses using microscope-integrated near-infrared angiography: a preliminary study","volume":"29","author":"Holm","year":"2009","journal-title":"Microsurgery"},{"key":"10.1016\/j.avsg.2020.12.018_bib0014","first-page":"582","article-title":"Injuries of the radial and ulnar arteries. In Proceedings of the American Society for Surgery of the Hand","volume":"49","author":"Boswick","year":"1967","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.avsg.2020.12.018_bib0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/micr.1006","article-title":"Multifactorial effects on the patency rates of forearm arterial repairs","volume":"21","author":"Bacakoglu","year":"2001","journal-title":"Microsurgery"},{"key":"10.1016\/j.avsg.2020.12.018_bib0016","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cyto.2011.03.014","article-title":"IL-6, but not TNF-\u03b1, increases plasma YKL-40 in human subjects","volume":"55","author":"Nielsen","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.avsg.2020.12.018_bib0017","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/bjd.14376","article-title":"Clinical significance of serum YKL-40 in Beh\u00e7et disease","volume":"174","author":"Seo","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.avsg.2020.12.018_bib0018","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/eye.2013.92","article-title":"Serum YKL-40 levels as a novel marker of inflammation and endothelial dysfunction in patients with pseudoexfoliation syndrome","volume":"27","author":"T\u00fcrky\u0131lmaz","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.avsg.2020.12.018_bib0019","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1475-2840-8-61","article-title":"YKL-40\u2014an emerging biomarker in cardiovascular disease and diabetes","volume":"8","author":"Rathcke","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.avsg.2020.12.018_bib0020","doi-asserted-by":"crossref","first-page":"40507","DOI":"10.18632\/oncotarget.5943","article-title":"Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization","volume":"6","author":"Shao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.avsg.2020.12.018_bib0021","doi-asserted-by":"crossref","first-page":"15332","DOI":"10.1074\/jbc.M110.212514","article-title":"Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma","volume":"286","author":"Francescone","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.avsg.2020.12.018_bib0022","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1158\/1055-9965.EPI-07-2766","article-title":"Diurnal, weekly, and long-time variation in serum concentrations of YKL-40 in healthy subjects","volume":"17","author":"Johansen","year":"2008","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.avsg.2020.12.018_bib0023","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11010-014-2277-y","article-title":"Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?","volume":"400","author":"Erfan","year":"2015","journal-title":"Mol Cell Biochem"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509621000728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509621000728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:03:13Z","timestamp":1760187793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509621000728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":23,"alternative-id":["S0890509621000728"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2020.12.018","relation":{},"ISSN":["0890-5096"],"issn-type":[{"type":"print","value":"0890-5096"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between Serum YKL-40 Level and Forearm Arterial Patency after Repair","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2020.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}